UBS Group’s Procaps Group PROC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-49
Closed -$115 – 11020
2024
Q4
$115 Buy
+49
New +$91 ﹤0.01% 9636
2024
Q2
– Sell
-42
Closed -$122 – 10272
2024
Q1
$122 Sell
42
-30,986
-100% -$112K ﹤0.01% 8807
2023
Q4
$126K Buy
+31,028
New +$90.4K ﹤0.01% 6051
2023
Q3
– Sell
-1
Closed -$4 – 10104
2023
Q2
$4 Buy
+1
New +$4 ﹤0.01% 8776
2023
Q1
– Sell
-852
Closed -$4.47K – 10613
2022
Q4
$4.47K Buy
+852
New +$5.56K ﹤0.01% 9332
2022
Q3
– Sell
-50
Closed – – 11087
2022
Q2
$0 Sell
50
-1,035
-95% -$8.58K ﹤0.01% 11107
2022
Q1
$9K Buy
1,085
+73
+7% +$657 ﹤0.01% 8575
2021
Q4
$10K Buy
1,012
+970
+2,310% +$9.46K ﹤0.01% 8810
2021
Q3
$0 Buy
+42
New – ﹤0.01% 10217

Other funds holding PROC

UBS Group's PROC Position: Q1 2025 in Review

UBS Group sold out of Procaps Group (PROC) in Q1 2025, closing a stake of 49 shares — an estimated $115 sold.

UBS Group first reported a position in PROC in Q3 2021 and held it in 9 quarters. The position peaked at $126K in Q4 2023. 1 fund tracked by Wall St. Rank holds PROC as of Q1 2025.

  • UBS Group reported no remaining Procaps Group position as of Q1 2025 after selling out during the quarter.
  • UBS Group sold 49 Procaps Group shares in Q1 2025, an estimated $115.
  • UBS Group first reported a position in Procaps Group in Q3 2021 and held it in 9 quarters.
  • UBS Group's Procaps Group position peaked at $126K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Procaps Group as of Q1 2025.

Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.